Talk:Hürthle cell neoplasm

Wiki Education Foundation-supported course assignment
This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Tlawt001.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 22:45, 17 January 2022 (UTC)

Hürthle Cell adenoma is a rare condition, often seen in women between the ages of seventy and eighty years old. This adenoma is often characterized by a mass of Hürthle cells. This mass is mostly benign, but may be malignant. If the mass is malignant, the mass is referred as a Follicular Thyroid Cancer or a Hürthle Cell Carcinoma.

Histology
Hürthle cell are characterized as enlarged epithelial cells. These cells, when stained are pink in color. This is due to the abundant mitochondria within the cell. These cells are often found in the Thyroid. The thyroid is a butterfly-shaped organ, responsible for producing various hormones and metabolism. These cells are often benign, but can be malignant and metastasize. Hürthle cells are resistant to radiation, but can be treated using radioactive iodine treatment.

Clinical Significance
Hürthle Cell adenoma is the benign case of Hürthle Cell Carcinoma. This adenoma is extremely rare, and in common in women. Often the adenoma is harmless but is removed after detection. This mass can be detected and removed before metastasis. The Tumor is often detected by X-Ray imaging and ultrasound. The location and size of the tumor may cause pressure and pain to the patient. But often the tumor goes undetected. After detection, the mass is tested using an invasive fine needle aspiration biopsy. — Preceding unsigned comment added by Tlawt001 (talk • contribs) 09:06, 16 November 2015 (UTC)

History
The first Hürthle Cell Adenoma was discovered by Dr. James Ewing in 1928. Hürthle cells were discovered in 1894, and are named after Karl Hürthle.